Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer
Vishnukamal Golla(University of California, Los Angeles), Stephen B. Williams(Cedars-Sinai Medical Center), Elias J. Farran(The University of Texas Medical Branch at Galveston), Alexander Yu(The University of Texas Medical Branch at Galveston), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Kevin Vu(The University of Texas Medical Branch at Galveston), Stephen J. Freedland(Cedars-Sinai Medical Center), Divya Ahuja Parikh(Stanford University), Courtney A. Stewart(The University of Texas Medical Branch at Galveston), Kirk A. Keegan(Vanderbilt University Medical Center), Yong Shan(The University of Texas Medical Branch at Galveston), Ali Raza Khaki(Palo Alto Institute), Todd A. Swanson(The University of Texas Medical Branch at Galveston), Douglas S. Tyler(University of North Carolina at Chapel Hill)
Urologic Oncology Seminars and Original Investigations
February 12, 2022
Cited by 15
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636